FMT Capsules for rCDI
Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age18+
SponsorHelsinki University Central Hospital
About this trial
Double blind RCT study of tretment of recurrent Clostridioides difficile infection by FMT capsules.
Eligibility criteria
Qualifiers
At least twice recurrent CDI*
Patient has had CDI-related diarrhea during infections (3 or more Bristol Stool Form Scale type 6-7 stools)
Other causes of diarrhea have been excluded based on clinical data
Age over 18 years
Disqualifiers
Pregnancy
Continuous need for antibiotic treatment
Previous anaphylactic reactions to any food
Gastroparesis
Trial design
Treatments tested in this trial
- Healthy donor stool
- placebo capsule
Treatment groups
76 Participants
are divided into 2 treatment groupsLocations
1Helsinki University Hospital00290, HelsinkiUusimaa, Finland
Sponsors and collaborators
Helsinki University Central Hospital
Lead sponsor
Source ClinicalTrials.gov